News Otsuka Initiates Voluntary Nationwide Recall of Certain Lots of Abilify® Tablets Dueto Drug Product Cross-Contamination on Manufacturing Equipment April 30, 2024 Read More » GENERIC DRUG APPROVALS April 30, 2024 Read More » NEWLY APPROVED DOSAGE FORMS April 30, 2024 Read More » HERCESSI™ April 29, 2024 Read More » LIBERVANT™ April 29, 2024 Read More » XOLREMDI™ April 29, 2024 Read More » BEQVEZ™ April 26, 2024 Read More » PIVYA April 24, 2024 Read More » OJEMDA April 23, 2024 Read More » Page1 … Page7 Page8 Page9 Page10 Page11 … Page43 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required) Email(Required) Comment(Required) Company Name(Required) CAPTCHA
Otsuka Initiates Voluntary Nationwide Recall of Certain Lots of Abilify® Tablets Dueto Drug Product Cross-Contamination on Manufacturing Equipment April 30, 2024 Read More »